Neuronal degeneration that occurs in both ischemia and degenerative neurologic illnesses may involve excitotoxic mechanisms.
In the present study, we examined whether cortical lesions with agonists acting at subtypes of glutamate receptors result in selective patterns of neuronal death. Injections of quinolinic acid, NMDA, homocysteic acid, kainic acid (KA), and a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (AMPA) were made at 2 sites in the dorsolateral frontoparietal cortex in rats. After 1 week, the cerebral cortex was either dissected for neurochemical studies, or animals were perfused for histologic evaluation. Concentrations of somatostatin (SS), neuropeptide Y (NPY), substance P (SP), cholecystokinin (CCK), and vasoactive intestinal polypeptide (VIP) were measured by radioimmunoassay, while amino acids and catecholamines were measured by high-performance liquid chromatography (HPLC) with electrochemical detection. NMDA agonists (quinolinic acid, homocysteic acid, and NMDA itself) resulted in dose-dependent reductions in glutamate and GABA, while SS, NPY, SP, CCK, and VIP were either unchanged or significantly increased in concentration. KA and AMPA at doses that resulted in comparable GABA depletions caused significant reductions in SS concentrations. Markers of cortical afferents were spared. All excitotoxins resulted in dose-dependent marked increases in uric acid concentrations.
Histologic examination verified that lesions with NMDA agonists produced relative sparing of NADPH-diaphorase, SS, VIP, and CCK neurons. These results show that NMDA excitotoxin lesions result in a pattern of selective neuronal damage in the cerebral cortex that is similar to that which occurs in both ischemia and Huntington's disease.
An accumulating body of evidence suggests the involvement of acidic amino acid receptors in a variety of neuropathologic states, including ischemia and hypoglycemia (Simon et al., 1984; Wieloch, 1985; Choi, 1988) . Excitatory amino acids may also play a role in Alzheimer's disease (AD, Greenamyre et al., 1988) . The possibility that an excitotoxic process may occur in Huntington's disease (HD) was initially proposed on the basis of both pathologic and neurochemical similarities with excitotoxin lesions (Coyle and Schwartz, 1976; McGeer and McGeer, 1976; Schwartz et al., 1984) . We found that striatal excitotoxin lesions with NMDA agonists provide a more accurate model of HD than those with other excitotoxins, because they result in relative sparing of somatostatin (SS) and neuropeptide Y (NPY) as compared with GABA and substance P (SP), similar to findings in HD (Beal et al., 1986a (Beal et al., , 1989 . The possibility of an NMDA excitotoxin mechanism in HD has been strengthened by the observation that NMDA receptors are preferentially depleted in the HD striatum .
We recently found that both ischemia and HD result in selective patterns of neuronal vulnerability in the cerebral cortex (Beal et al., 1988b; Cudkowicz and Kowall, 1990; Uemura et al., 1990) . Differential vulnerability of cortical neurons in AD is also suggested by both neurochemical and histologic studies Kowall and Beal, 1988) . A suitable animal model of these illnesses should replicate the same pattern of neuronal vulnerability. In the striatum in vivo and in cortical and striatal cell cultures in vitro, excitotoxin lesions with NMDA and non-NMDA excitatory amino acid agonists show differing patterns of neuronal susceptibility (Koh and Choi, 1988a,b; Beal et al., 1989) . In the present study, we examined the effects of lesions in the cerebral cortex with NMDA, kainic acid (KA), and quisqualate agonists, to determine whether lesions with particular agonists could mimic the patterns of neuronal degeneration seen in either ischemia or neurodegenerative illnesses.
Materials and Methods
Kainic acid, quinolinic acid, homocysteic acid, and N-methyl-n-aspartate were obtained from Sigma (St. Louis, MO), while a-amino-3-hydroxy-5-methylisoxazole-4-proprionicacid (AMPA) was obtained from Research Biochemicals (Wayland, MA). Male Spragut+Dawley rats (Charles River) weighing 150-l 75 gm were anesthetized with pentobarbital (50 mg/kg, i.p.). Compounds were dissolved in 1 pl phosphatebuffered saline (pH, 7.4) and were injected into the left dorsolateral frontoparietal cortex at 2 sites: 1.7 mm anterior to the bregma, 2.0 mm lateral, 2.6 mm ventral to the skull surface; and 1.8 mm posterior to the bregma, 3.0 mm lateral, 2.3 mm ventral to the skull. The incisor bar (Kopf stereotaxic) was set at -3.3 mm. Injections were made with a lo-p1 Hamilton syringe fitted with a 30-gauge blunt-tipped needle. All injections were made over 1 min, and the needle was left in place for a further 2 min before being slowly withdrawn.
Ten animals were lesioned at each dose of excitotoxin. All animals survived for 1 week and were killed by decapitation, their brains were promptly removed, and the dorsolateral cerebral cortex was dissected from a 3-mm-thick slice, using a Plexiglas brain template (Zivic-Miller) . The left and right cerebral cortex were placed in 1 ml chilled 0.1 N HCl. Samples were sonicated, frozen, and thawed twice, and 2 aliquots were taken for analysis of catecholamines and amino acids. The remaining sample was boiled and centrifuged. Aliquots of supematant were lyophilized for radioimmunoassays. Protein determinations were made on the pellet using a fluorometric assay (Bohlen et al., 1973) . Radioimmunoassays for somatostatinlike immunoreactivity, neuropeptide Y-like immunoreactivity, substance P-like immunoreactivity, vasoactive intestinal polypeptide-like immunoreactivity, and cholecystokinin-like immunoreactivity were carried out as previously described (Arnold et al., 1982; Abe et al., 1985; Beal et al., 1986b; Mazurek et al., 1989a) . Amino acids were measured by high-performance liquid chromatography (HPLC) with electrochemical detection (Ellison et al., 1987) . Catecholamines and related compounds were assayed by a novel HPLC technique with 16-channel electrochemical detection (Matson et al., 1987) .
A total of 12 animals was used for histochemical studies. Four groups of 3 animals were lesioned with quinolinic acid (240 nmol), NMDA (240 nmol), KA (10 nmol), or AMPA (15 nmol). After 1 week of survival, animals were deeply anesthetized with pentobarbital and perfused with 0.25% sodium nitrite in 0.9% saline. followed bv fixation with 4% paraformaldehyde and 0.02% glutaraldehyde in 0.1 G phosphate buffer (pH, 7.3). Brains were removed, washed in phosphate buffer, and cut at 50 pm on a vibratome. Sets of sections were placed in normal goat serum in phosphate-buffered saline (PBS) for 1 hr, followed by incubation overnight at room temperature in antisera to SS (1: 1000; ICN), VIP ( 1: 1000; Incstar), CCK ( 1: 1000; Incstar), and SMI-32 (a monoclonal antibody that recognizes a phosphatase-insensitive epitope on the medium and heavy chain of the neurofilament polypeptide; 1:5000; Stemberger-Meyer). Somatostatin, VIP, and CCK immunoreactivity are located in cortical local circuit neurons, whereas SMI-32 is found in a subset of cortical pyramidal projection neurons that are sensitive to degeneration in HD (Cudkowicz and Kowall, 1990) . After washes in PBS and incubation in the appropriate peroxidase-conjugated secondary antibodies, immunoreactivity was disclosed using diaminobenzidine as the chromagen (Kowall and Beal, 1988) . Adjacent sections were stained with cresyl violet. Cortical sections from animals lesioned with NMDA or KA were stained for NADPH-diaphorase with a cresyl violet counterstain as previously described (Beal et al., 1989) .
The injections resulted in several-millimeter-wide regions of dense gliosis surrounding the needle tract in which there were few remaining neurons. Examination of coronal sections at a level where the lesion was clearly visible showed a small transition zone of partial neuronal depletion extending from the intensely lesioned areas to normal-appearing cortex. Neuronal counts of immunoreactive or NADPH-diaphorase neurons were made on coronal sections by 2 independent observers through the depth of the cortex across a 1.5-mm traverse immediately around the injection site and 2 flanking 1.5-mm regions of adjacent cortex. Neuronal counts were also manually performed on cresyl violet-stained sections and NADPH-diaphorase-cresyl violetstained sections in a series of random 320x fields within the same regions.
The neurochemical measurements were compared to the unlesioned (control) side and expressed as the percentage of control. The unlesioned control sides were compared with saline-injected contralateral unlesioned control sides. There were no significant neurochemical differences from the saline controls on the unlesioned side, except for NPY, as discussed below. The results are expressed as the mean f standard error of the mean. Comparisons were made using unpaired Student's t test (2-tailed) or l-way analysis of variance (ANOVA).
Results
The levels of the various neurotransmitters examined in the saline-injected control cerebral cortex are shown in Table 1 . There were no significant differences in neurochemical markers between the unlesioned side in the saline controls and that in the excitotoxin-treated animals, except for NPY. NPY concentrations were significantly increased, approximately 40% from 2.11 f 0.08 pmol/mg protein to a mean of 2.95 + 0.13, in the unlesioned side of the excitotoxin-treated animals. Bilateral increases in cortical NPY concentrations have also been observed with electroconvulsive shocks (Wahlestedt et al., 1990) and may have resulted from seizures in our animals. The increases on the unlesioned side were uniform in all groups with no significant differences among the groups. Increases of NPY on the lesioned side of the excitotoxin-treated animals showed further increases over the unlesioned side. Concentrations of NPY were therefore compared with those on the unlesioned side.
The effects of increasing doses of NMDA agonists on neurochemical markers are shown in Figures l-3. All 3 NMDA agonists (NMDA, quinolinic acid, and L-homocysteic acid) produced a similar pattern of neurochemical changes. There were mild dose-dependent significant reductions in glutamate, while aspartate showed no significant changes. Reductions in GABA were also dose dependent and reached a maximum of 3WO% at the highest doses examined. In contrast, none of the neuropeptides showed significant depletions. NMDA resulted in significant increases of NPY, SP, and CCK. Quinolinic acid resulted in significant increases of SS and NPY, while homocysteic acid resulted in significant increases in SS, NPY, SP, and CCK. VIP concentrations showed no significant changes with any of the NMDA agonists. The increases in SS and NPY were greatest at the lowest doses of the excitotoxins, and decreased with increasing doses. This finding is consistent with relative but not absolute sparing of these neurons, which do show some vulnerability at high dose levels. In contrast, both SP and CCK showed larger increases with larger doses of the excitotoxins. Both AMPA and KA resulted in dose-dependent significant decreases in GABA concentrations (Figs. 4,5) . The highest doses examined resulted in GABA depletions comparable to those induced by NMDA agonists. In contrast to the NMDA agonists, however, both these compounds resulted in significant reductions in SS concentrations. The highest dose of KA (20 nmol) also resulted in a significant depletion of SP. NPY, VIP, and CCK showed no significant changes with KA. NPY and SP were unchanged with AMPA lesions. Unfortunately, there was insufficient sample to measure VIP and CCK with the AMPA lesions.
The results of measurements of catecholamines and related compounds are shown in Tables 211. The lesions were axon sparing because there were no significant changes in concentrations of norepinephrine, dopamine, or serotonin. There was, however, evidence of increased dopamine and serotonin tumover as evidenced by dose-dependent significant increases in concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid, and 5hydroxyindoleacetic acid. Both tryptophan and tyrosine also were increased within the lesioned areas, particularly at the higher doses of the excitotoxins. The most striking neurochemical changes were dose-dependent significant increases in uric acid concentrations, with much smaller cerebral cortex. Sparing of NADPH-diaphorase, SS, VIP, and CCK neurons was seen with both NMDA and quinolinic acid. This sparing was much more striking than the sparing of NADPH-diaphorase neurons we previously observed in the transition zone of striatal lesions with NMDA agonists (Beal et al., 1989) . There was some depletion of neuropeptide neurons, but it was not significant. With NMDA lesions, the mean numbers of neurons in a 1.5mm traverse of the unlesioned adjacent tissue as compared with those in the lesioned areas were SS, 62.4 f 29.3 versus 52.3 f 25.4; CCK, 10.7 f 0.7 versus 7.7 f 0.9; and VIP, 46.7 f 9.5 versus 38.3 f 11.2. The normal pattern of SMI-32-immunoreactive pyramidal neurons in layers III and V was interrupted surrounding the injection site, while 
Discussion
The neuroexcitatory and neurotoxic effects of excitatory amino acids are mediated by several types of postsynaptic receptors, commonly designated by the preferred agonists NMDA, kainate, and quisqualate (Fagg et al., 1986) . More recently, it has been shown that quisqualate activates 2 types of receptors. One receptor opens a membrane ionophore and is selectively activated by AMPA, while the second receptor acts via G-proteins to activate phospholipase C and is referred to as the "metabotropic" quisqualate receptor. Both NMDA and non-NMDA (Beal et al., 1986a (Beal et al., , 1989 . It is also possible that Studies in vitro show that much more prolonged exposure is non-NMDA receptors play a role in the pathogenesis of amyorequired for non-NMDA agonists to produce neuronal death trophic lateral sclerosis, or even AD (Spencer et al., 1987; Green- (Koh et al., 1990) . amyre et al., 1988; Weiss et al., 1989) . The role of NMDA and non-NMDA receptor agonists in
In partial ischemia, and also in HD and AD, there are selective neurologic diseases is under investigation. The most compelling patterns of neuronal death in the cerebral cortex. These patterns evidence has linked NMDA receptors to neuronal degeneration of neurotransmitter alterations in neurological diseases provide in both ischemia and hypoglycemia (Choi, 1988) . In experia background upon which one can test the validity of experimental models of both these conditions, neuronal damage can mental models of neurological illness. The present study therebe blocked with NMDA antagonists (Simon et al., 1984; Wie- fore examined whether excitotoxin lesions induced by agonists loch, 1985). There is also evidence that HD may be mediated acting at the subtypes of acidic amino acid receptors can repby an NMDA-induced excitotoxic process. There is a preferlicate the selective patterns of neuronal damage seen in several ential loss of NMDA receptors in the HD putamen (Young et neurologic illnesses. Lesions with NMDA agonists (NMDA, al., 1989) . In addition, NMDA excitotoxic striatal lesions show quinolinic acid, and homocysteic acid) produced differential both pathologic and neurochemical similarities to HD, includeffects in the cerebral cortex as compared with lesions induced ing relative sparing of choline@ and somatostatin-neuropep-by the non-NMDA agonists AMPA and kainate. Increasing doses of NMDA agonists resulted in dose-dependent reductions of both glutamate and GABA, whereas there were no significant reductions in aspartate or a variety of neuropeptides. The extent of glutamate depletion is probably an underestimate of the extent of glutamate@ neuronal depletion, due to the presence of glutamate in both metabolic and neurotransmitter pools. Both NPY and SS showed significant increases, which were most marked at the lowest doses of the excitotoxins, and decreased with increasing doses, consistent with a relative but not absolute sparing of cortical neurons containing SS and NPY. SP and CCK showed significant increases at higher doses of NMDA agonists, while VIP was unchanged.
In contrast, lesions with non-NMDA agonists, which produced a comparable depletion of GABA to those with NMDA agonists, resulted in significant reductions of SS. SP was also depleted at the highest dose of KA. The histologic studies confirmed a relative sparing of NADPH-diaphorase, SS, VIP, and CCK neurons with NMDA agonists, in regions in which there was a marked depletion of pyramidal neurons (Figs. 6-8 ). In contrast with both KA and AMPA, there were significant depletions of NADPH-diaphorase and SS neurons. NMDA lesions depleted NADPH-diaphorase and SS neurons approximately 20%, whereas the non-NMDA lesions resulted in an approximately 70% depletion. The sparing of NADPH-diaphorase and SS neurons was more striking in the cerebral cortex than that which occurs in the striatum. In the striatum, there is a marked depletion of the NADPH-diaphorase neurons in the center of the lesion, and sparing relative to enkephalin neurons can only be shown in the transition zone at the periphery of the lesion (Beal et al., 1989) . A relative sparing of NADPH-diaphorase neurons in cortical cell cultures was initially reported by Koh et al. (1986) . These authors demonstrated that NADPH-diaphorase neurons were relatively spared in response to NMDA agonists, yet were preferentially depleted as compared with the total neuronal population in response to either quisqualate or kainate (Koh and Choi, 1988b) . At extremely high doses of either NMDA or quinolinate, the NADPH-diaphorase neurons were depleted, consistent with a relative but not absolute resistance to these agents. Our present neurochemical findings are in accord with this. One previous immunocytochemical study of quinolinic acid lesions in the cerebral cortex also showed sparing of SS, NPY, and NADPH-diaphorase neurons, consistent with our present findings (Boegman and Parent, 1988) . The finding that GABA concentrations are depleted following NMDA lesions appears at variance with the recent observation that GABAergic neurons are relatively spared by NMDA excitotoxin lesions in cortical cultures (Tecoma and Choi, 1989) . GABAergic neurons in the cerebral cortex, however, comprise several subpopulations. GABAergic neurons can be divided into 2 classes, containing either parvalbumin or calbindin (Hendry et al., 1989) . CCK, SP, SS, and NPY neurons all show colocalization with GABA in the cerebral cortex (Jones, 1986) . The present findings suggest that this population of GABAergic neurons is resistant to NMDA, while other populations may not show comparable resistance. It is of interest that VIP, which does not colocalize with GABA (Jones, 1986) , was the one neuropeptide that did not show significant increases following NMDA lesions.
The most plausible explanation for relative sparing of neuropeptide-containing interneurons following NMDA cortical lesions is that these neurons receive fewer excitatory amino acid afferents, and exhibit fewer NMDA receptors, than other neurons. Consistent with this notion, a recent ultrastructural study of NPY neurons in both the cerebral cortex and the striatum showed that synaptic inputs to proximal dendrites and somata were rare, as compared with neighboring neurons (Aoki and Pickel, 1989) . This suggests that fewer and weaker inputs may modulate the excitability of NPY-containing neurons. GABAergic neurons receive both excitatory and inhibitory afferents, but the relative proportions are unclear (DeFelipe and Jones, 1985) . Most dendritic spines that are postsynaptic to glutamatergic terminals probably arise from pyramidal neurons (Conti et al., 1989) , which may account for the vulnerability of these neurons.
The present studies confirm previous findings that cortical afferents are spared by excitotoxin lesions (Isacson et al., 1988) . There was no significant depletion of norepinephrine, dopamine, or serotonin. This is consistent with other studies showing no alteration in ChAT activity in the cerebral cortex following excitotoxin lesions (Isacson et al., 1988) . There were significant Lesi ons i n the Cerebral Cortex dose-dependent increases in both dopamine and serotonin metabolites, consistent with increased turnover. Similar findings occur with striatal lesions at 1 week (Aldinio et al., 1985; Mazzari et al., 1986) . There were also increased concentrations of both tryptophan and tyrosine, which may reflect neovascularization after the lesions, with increased transport into the brain (Iadecola et al., 1989; Shigematsu et al., 1989) . The most striking finding was marked (5-l O-fold) dose-dependent significant increases in uric acid concentrations with all excitotoxin lesions examined. There were also increases in xanthine concentrations, but these were much less marked. Increased uric acid concentrations, therefore, are an extremely sensitive marker of excitotoxin lesions. We have recently observed similar increases in uric acid following striatal lesions at 7 d, but levels are normal at 3 and 6 months (M. F. Beal et al., unpublished observations) . The finding of increased uric acid concentrations is of uncertain significance. Several stimuli, including drug administration, feeding and drinking behavior, and motivated lever pressing, result in increased extracellular levels of uric acid (Kendrick et al., 1986; Mueller, 1987; Joseph et al., 1989; O'Neill, 1990) . Excitatory amino acids can also release 3H-adenosine from the cerebral cortex in vivo (Perkins and Stone, 1983) . Increased uric acid could therefore represent a degradation product of adenosine (O'Neill, 1986) . Alternatively, because uric acid is derived from purines, which are involved in cellular energy metabolism, it may be an index of regional metabolic activity. This latter possibility is supported by observations in the ischemic brain showing marked increases in xanthine and uric acid for up to 48 hr following middle cerebral artery occlusion (Kanemitsu et al., 1988) . Striatal glucose metabolism remains elevated 5 dafter an ibotenic acid lesion (Owman et al., 1983) though after several weeks, there are significant reductions in glucose metabolism (Isacson et al., 1984) .
The present findings show several similarities in the pattern of neuronal degeneration that occurs following ischemia and in the HD cerebral cortex, as compared with that seen following NMDA excitotoxin lesions in the cerebral cortex. With ischemia in the neonatal cerebral cortex, both concentrations of SS and NPY and numbers of NADPH-diaphorase neurons are spared (Ferriero et al., 1988) . We found similar sparing of NADPHdiaphorase neurons, as well as preservation of SS, NPY, and SP concentrations, following cortical ischemic damage in adult gerbils (Uemura et al., 1990) . VIP neurons in the frontoparietal cortex and the hippocampus are also spared by transient forebrain ischemia (Grimaldi et al., 1989) . Some GABAergic neurons in the cerebral cortex are vulnerable to ischemia (Sloper et al., 1980; Romijn, 1989) , though other populations in the hippocampus are resistant (Johansen et al., 1989; Nitsch et al., 1989) . Pyramidal neurons appear to be particularly vulnerable to ischemia (Iizuka et al., 1989) .
In HD, there has been uncertainty concerning the extent of pathologic involvement in the cerebral cortex. A recent morphometric study showed a marked reduction in the volume of the cerebral cortex (de la Monte et al., 1988) . Our recent neurochemical studies showed marked increases in CCK, NPY, and VIP concentrations, with smaller increases in SS and SP (Beal et al., 1988a (Beal et al., , 1989b Mazurek et al., 1989a,b) . Glutamate concentrations were either unchanged or showed small decreases (Ellison et al., 1987) , consistent with another report (Reynolds and Pearson, 1987) . These findings are consistent with a loss of pyramidal neurons containing glutamate and relative sparing or up-regulation of neuropeptide-containing interneurons. In support of this, our recent immunohistochemical studies showed preservation of NPY neurons despite a loss of neurofilamentstained pyramidal neurons in the HD cerebral cortex (Cudkowicz and .
The present findings provide further evidence favoring an NMDA excitotoxin mechanism both in ischemic cortical damage and in HD. NMDA excitotoxic lesions in the cerebral cortex are similar to findings in ischemia in that there is a depletion of both GABAergic and pyramidal neurons, yet a relative preservation of NADPH-diaphorase and VIP neurons. In the HD cerebral cortex, there is a depletion of pyramidal neurons, yet a preservation of neuropeptide Y neurons, as seen with NMDA excitotoxin lesions. In addition, there are increases in concentrations of neuropeptides consistent with findings following NMDA excitotoxin lesions. It is of interest that the largest and most consistent increases were in NPY and CCK, similar to findings in HD. GABA concentrations are not significantly depleted in HD, in contrast to what we observed with excitotoxin lesions. Other studies, however, have shown that, following chronic excitotoxin lesions, the cerebral cortex shrinks, and glutamic acid decarboxylase activity, a marker of GABAergic neurons, returns to normal (Isacson et al., 1988) . Atrophy of the cerebral cortex in HD may therefore account for the normal GABA concentrations, despite a loss of GABAergic neurons.
In AD, there are reductions in SS concentrations, as well as morphologic changes in SS neurons (Beal et al., 1986~; Kowall and Beal, 1988) . Other neuropeptides, however, are much less affected . This pattern of neurotransmitter involvement was most closely replicated by non-NMDA receptor agonists in the present study. Cortical lesions with non-NMDA agonists also result in shrinkage of the large basal forebrain cholinergic neurons, as well as reductions in cortical ChAT activity, similar to findings in AD (Isacson et al., 1988) .
The present findings show that excitotoxin lesions with NMDA and non-NMDA agonists result in selective patterns of neuronal degeneration. They provide further circumstantial evidence that excitatory amino acid receptors may be involved in the pathogenesis of both acute and chronic neurologic illnesses.
